What is SegAna?
SegAna, LLC, operates within the medical technology sector, specializing in software solutions designed for near real-time treatment guidance in adaptive radiotherapy. This technology facilitates enhanced clinical decision-making for physicians. Additionally, the company manufactures and markets deformable four-dimensional lung phantom simulators. These advanced simulators are crucial for improving lung cancer radiation treatment protocols by allowing physicians to train with patient-specific lung details to develop precise treatment parameters.
How much funding has SegAna raised?
SegAna has raised a total of $100K across 1 funding round:
Debt
$100K
Debt (2021): $100K with participation from PPP
Key Investors in SegAna
PPP
Public-Private Partnership
What's next for SegAna?
With the recent influx of capital from a major strategic investment, SegAna is poised for significant growth and further development of its innovative radiotherapy guidance software and specialized phantom simulators. The company's focus on precision in adaptive radiotherapy suggests a strategic direction towards refining treatment efficacy and patient outcomes. This substantial backing, part of its overall $100K in financing, will likely fuel advancements in product development, market expansion, and the scaling of manufacturing capabilities for its unique lung phantom simulators, positioning SegAna as a key player in advanced cancer treatment technologies.
See full SegAna company page
